Skip to main content
Lisinopril Tablets IP 2.5 mg Exporter

Lisinopril Tablets IP 2.5 mg Exporter in India – Healthy Inc

Lisinopril Tablets IP 2.5 mg Exporter product packaging

Lisinopril Tablets IP 2.5 mg | Exporter

Product image for Lisinopril Tablets IP 2.5 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameLisinopril
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049071
PharmacopoeiaIP
Product TypeTablet
CategoryAntihypertensive drugs – ACE Inhibitor
SubcategoryACE Inhibitor
Active IngredientLisinopril
Strength2.5 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntihypertensive drugs – ACE Inhibitor

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Lisinopril Tablets IP 2.5 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. First-line management of mild, moderate, and severe essential hypertension. 2. Adjunctive treatment in chronic stable angina pectoris and reduction of cardiovascular mortality.
Full Description

Healthy Inc invites international procurement enquiries for Lisinopril Tablets IP 2.5 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameLisinopril
CompositionLisinopril
Strength2.5 mg
CategoryAntihypertensive drugs – ACE Inhibitor
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Lisinopril Tablets IP 2.5 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally once or twice daily at the same time each day, with or without food. Do not discontinue abruptly; gradual downward titration is recommended under medical supervision.
Side EffectsCommon: Peripheral edema (ankle swelling), dizziness, headache, flushing, fatigue. Uncommon: Postural hypotension, palpitations, dyspepsia, dry cough, muscle cramps. Rare: Bradycardia, severe hypotension, syncope, hyperkalemia, angioedema.
Warnings and PrecautionsHypotension Monitoring: Monitor seated blood pressure during initial titration. Electrolyte Balance: Periodically verify serum potassium and renal clearance in patients with underlying renal insufficiency. Heart Failure Caution: Use with careful clinical assessment in heart failure patients.
Contraindications1. Hypersensitivity to Lisinopril or related cardiovascular agent classes.
2. Severe cardiogenic shock, second- or third-degree atrioventricular block without a pacemaker.
3. Clinically severe hypotension (systolic BP < 90 mmHg).
4. Pregnancy and lactation (for ACE inhibitors and ARBs).
Drug Interactions1. Other Antihypertensives & Diuretics: Additive blood-pressure-lowering effects requiring monitored dose titration.
2. Potassium Supplements & Potassium-Sparing Diuretics: Elevated risk of hyperkalemia (with RAAS blockers).
3. NSAIDs: May diminish antihypertensive response and increase risk of acute renal dysfunction.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Lisinopril Tablets IP 2.5 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Lisinopril Tablets IP 2.5 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Lisinopril Tablets IP 2.5 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Lisinopril Tablets IP 2.5 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Lisinopril Tablets IP 2.5 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Hashtags

#Lisinopril#Exporter#PharmaB2B

Related Products

Latest Posts